| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MANNKIND CORP | EVP Endocrine Business Unit | Common Stock, $0.01 Par Value | 777K | $3.11M | $4.00 | 22 Aug 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MNKD | MANNKIND CORP | 22 Aug 2022 | 2 | -$17.8K | 4 | EVP Endocrine Business Unit | 23 Aug 2022, 21:00 |
| MNKD | MANNKIND CORP | 31 Jul 2022 | 1 | $14.7K | 4/A | EVP Endocrine Business Unit | 24 Aug 2022, 21:00 |
| MNKD | MANNKIND CORP | 18 May 2022 | 1 | $15.3K | 4/A | EVP Endocrine Business Unit | 25 May 2022, 20:00 |
| MNKD | MANNKIND CORP | 18 May 2022 | 1 | -$15.3K | 4 | EVP Endocrine Business Unit | 20 May 2022, 20:00 |
| MNKD | MANNKIND CORP | 10 May 2022 | 2 | $0 | 4 | EVP Endocrine Business Unit | 12 May 2022, 20:01 |
| MNKD | MANNKIND CORP | 28 Feb 2022 | 1 | $100K | 4/A | EVP Endocrine Business Unit | 24 Aug 2022, 21:00 |
| MNKD | MANNKIND CORP | 28 Feb 2022 | 1 | $100K | 4 | Chief Commercial Officer | 01 Mar 2022, 16:01 |
| MNKD | MANNKIND CORP | 31 Jan 2022 | 1 | $5.72K | 4/A | EVP Endocrine Business Unit | 24 Aug 2022, 21:00 |
| MNKD | MANNKIND CORP | 31 Jan 2022 | 1 | $5.72K | 4/A | Chief Commercial Officer | 09 Feb 2022, 20:00 |
| MNKD | MANNKIND CORP | 27 Aug 2021 | 1 | -$47.2K | 4 | Chief Commercial Officer | 27 Aug 2021, 21:01 |
| MNKD | MANNKIND CORP | 30 Jul 2021 | 1 | $15K | 4 | Chief Commercial Officer | 02 Aug 2021, 20:00 |
| MNKD | MANNKIND CORP | 18 May 2021 | 2 | $0 | 4 | Chief Commercial Officer | 20 May 2021, 17:00 |